Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma - A single institution experience

被引:32
作者
Chen, Weina [1 ]
Karandikar, Nitin J. [1 ]
McKenna, Robert W. [1 ]
Kroft, Steven H. [1 ]
机构
[1] Univ Texas, SW Med Sch, Dallas, TX 75230 USA
关键词
flow cytometry; precursor B-lymphoblastic leukemia/lymphoma; precursor B-ALL; immunophenotypic stability; minimal residual disease;
D O I
10.1309/7R6MU7R9YWJBY5V4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Essentially all cases of precursor B-lymphoblastic leukemia/dymphoma (B-ALL) demonstrate multiple immunophenotypic aberrancies relative to normal maturing B-cell precursors (hematogones). The stability of these aberrancies has relevance to follow-up minimal residual disease analysis. We compared the immunophenotypes at diagnosis and relapse in 51 childhood and adult B-ALLs with flow cytometry (FC) using broad antibody; panels. A total of 446 aberrancies were present at diagnosis (median, 9 per case; range, 2-14). All cases retained multiple aberrancies at relapse (median, 8 per case; range, 2-14). Antibody panels at relapse allowed assessment of 383 (85.9%) of the initial 446 aberrancies. Of these, 299 (78.1%)were persistent and 84 (21.9%) were lost at relapse. Overall, 73% of cases showed a loss of at least I aberrancy at relapse. However new aberrancies were detected in 60% of cases. These findings suggest that FC is suitable for the detection of residual B-ALL, provided that follow-up studies are not too narrowly targeted.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 29 条
[1]  
ABSHIRE TC, 1992, LEUKEMIA, V6, P357
[2]   ANALYSIS OF IG AND T-CELL RECEPTOR GENES IN 40 CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS AT DIAGNOSIS AND SUBSEQUENT RELAPSE - IMPLICATIONS FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION ANALYSIS [J].
BEISHUIZEN, A ;
VERHOEVEN, MAJ ;
VANWERING, ER ;
HAHLEN, K ;
HOOIJKAAS, H ;
VANDONGEN, JJM .
BLOOD, 1994, 83 (08) :2238-2247
[3]   Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia [J].
Björklund, E ;
Mazur, J ;
Söderhäll, S ;
Porwit-MacDonald, A .
LEUKEMIA, 2003, 17 (01) :138-148
[4]   Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group [J].
Borowitz, MJ ;
Pullen, DJ ;
Winick, N ;
Martin, PL ;
Bowman, WP ;
Camitta, B .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 68B (01) :18-24
[5]   Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia [J].
Coustan-Smith, E ;
Sancho, J ;
Behm, FG ;
Hancock, ML ;
Razzouk, BI ;
Ribeiro, RC ;
Rivera, GK ;
Rubnitz, JE ;
Sandlund, JT ;
Pui, CH ;
Campana, D .
BLOOD, 2002, 100 (01) :52-58
[6]   Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia [J].
Coustan-Smith, E ;
Sancho, J ;
Hancock, ML ;
Boyett, JM ;
Behm, FG ;
Raimondi, SC ;
Sandlund, JT ;
Rivera, GK ;
Rubnitz, JE ;
Ribeiro, RC ;
Pui, CH ;
Campana, D .
BLOOD, 2000, 96 (08) :2691-2696
[7]  
Czuczman MS, 1999, BLOOD, V93, P3931
[8]   Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia [J].
Dworzak, MN ;
Fröschl, G ;
Printz, D ;
Mann, G ;
Pötschger, U ;
Mühlegger, N ;
Fritsch, G ;
Gadner, H .
BLOOD, 2002, 99 (06) :1952-1958
[9]  
GAGNON GA, 1989, BLOOD, V74, P2088
[10]   Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection [J].
Gaipa, G ;
Basso, G ;
Maglia, O ;
Leoni, V ;
Faini, A ;
Cazzaniga, G ;
Bugarin, C ;
Veltroni, M ;
Michelotto, B ;
Ratei, R ;
Coliva, T ;
Valsecchi, MG ;
Biondi, A ;
Dworzak, MN .
LEUKEMIA, 2005, 19 (01) :49-56